Orange
County, Calif. – (December 11, 2009)
-- Beckman
Coulter, Inc. and CompuCyte Corporation have entered
into a five-year global distribution agreement, under the
terms of which Beckman Coulter will have the right to
distribute CompuCyte laser scanning cytometers in cellular
analysis markets worldwide. Beckman Coulter will maintain
exclusive distribution rights for CompuCyte iGeneration
technology outside of North America, and will share with
CompuCyte the right to sell the instrumentation to research
institutions and pharmaceutical companies within the U.S.,
Canada and Mexico. CompuCyte will continue worldwide direct
sales of LSC instrumentation for automated tissue analysis.
“This
agreement provides us with a sophisticated imaging platform
that nicely complements our growing flow cytometry product
portfolio,” stated Brad Calvin, Beckman Coulter vice president
for flow cytometry. “The iGeneration line of imaging
cytometers will be an important addition to the range of
products we are launching. This will enable us to provide
researchers around the world with a broad range of technology
for cell-based research from a single service provider, while
further demonstrating our commitment to the research market.”
Dr. Elena
Holden, CompuCyte president and CEO, welcomes the new
agreement: “Our distribution alliance is built on a great
synergy between the two companies. Beckman Coulter is a
renowned leader in flow cytometry instrumentation and
CompuCyte is recognized as the first company to introduce
solid-phase imaging cytometry technology (LSC) to the
marketplace. LSC technology is complementary to flow
cytometry and applies similar analysis principles to adherent
cellular and tissue specimens, combining the resulting
analytic data with high-quality imaging. The agreement with
Beckman Coulter furthers CompuCyte’s commitment to the growing
quantitative imaging cytometry market by enlarging the LSC
technology distribution channel, and by bringing outstanding
technical support to our customers worldwide.”
About
Beckman Coulter
Beckman
Coulter, Inc., based in Orange County, California, develops,
manufactures and markets products that simplify, automate and
innovate complex biomedical tests. More than 200,000 Beckman
Coulter systems operate in laboratories around the world,
supplying critical information for improving patient health
and reducing the cost of care. Recurring revenue, consisting
of supplies, test kits and operating-type lease payments,
represents approximately 78 percent of the company's 2008
annual revenue of $3.1 billion. For more information, visit
www.beckmancoulter.com.
About
CompuCyte Corporation
CompuCyte
Corporation, a privately held corporation headquartered in
Westwood, Massachusetts, is a pioneer in the field of
quantitative imaging cytometry (QIC). The company’s
comprehensive line of laser scanning cytometry instrumentation
is applied to automated cellular and tissue analysis in life
science research, drug safety, toxicology studies and clinical
trials. Committed to educational programs and promotion of
the science and practice of LSC technology, CompuCyte actively
maintains the International QIC Centers of Excellence program
(www.imagingcytometrycenter.com)
and the annual International QIC Symposium. More information
about CompuCyte Corporation and its technology may be found at
www.compucyte.com.
Beckman
Coulter and the stylized logo are registered trademarks of
Beckman Coulter, Inc.
